Internal Medicine, Rheumatology · Floral Park, NY
NPI
1407070667
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
26701 Hillside Ave
Floral Park, NY, 11004
Phone (718) 343-7790
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
392 services
Medicare patients, 2024
52
Average age 69
Drug cost, 2024
$8.0M
7,945 prescriptions
Company payments, 2025
$1,578
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fatima M Khan was code 76881 (ultrasound - nonspecific), 78 times for 24 patients. In total Fatima M Khan billed 392 services in 15 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 76881 Ultrasound - Nonspecific | Office | 78 | 24 | $46.52 | $3,628 |
| 99214 Office E&M - Established | Office | 68 | 37 | $106.04 | $7,211 |
| 99213 Office E&M - Established | Office | 56 | 25 | $80.82 | $4,526 |
| 36415 Venipuncture Blood Collection | Office | 43 | 35 | $8.65 | $372 |
| 99215 Office E&M - Established | Office | 43 | 25 | $158.89 | $6,832 |
By year: 2022 $41K for 686 services; 2023 $48K for 877 services; 2024 $27K for 392 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 35 | $8.65 | $372 |
Medicare prescription drug claims, 2024
In 2024, the drug Fatima M Khan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 977 prescriptions and refills. In total Fatima M Khan wrote 7,945 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 977 | 1,144 | 221 | $19K |
| Methotrexate Methotrexate Sodium | 921 | 1,160 | 237 | $16K |
| Sulfasalazine Generic | 801 | 1,005 | 212 | $10K |
| Folic Acid Generic | 536 | 637 | 134 | $369 |
| Humira(Cf) Pen Adalimumab | 390 | 408 | 65 | $2.7M |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 383 | 459 | 114 | $460 |
| Rinvoq Upadacitinib | 333 | 337 | 51 | $2.1M |
| Rasuvo Methotrexate/Pf | 331 | 339 | 55 | $179K |
| Gabapentin Generic | 288 | 325 | 97 | $1,561 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 246 | 258 | 82 | $7,909 |
| Enbrel Sureclick Etanercept | 206 | 208 | 37 | $1.5M |
| Diclofenac Sodium Generic | 194 | 202 | 66 | $13K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 130 | 155 | 40 | $1,291 |
| Cyclobenzaprine Hcl Generic | 122 | 139 | 61 | $450 |
| Leflunomide Generic | 115 | 126 | 30 | $5,195 |
Brand drugs: 2,732 claims; generic drugs: 5,035 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fatima M Khan $1,578 ($1,578 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $871.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.